These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18370460)

  • 1. Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature.
    Beyer WE; Palache AM; Osterhaus AD
    Clin Drug Investig; 1998; 15(1):1-12. PubMed ID: 18370460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of immunogenicity and reactogenicity of split versus subunit influenza vaccine in Korean children aged 6-35 months.
    Kim YK; Eun BW; Kim NH; Kang EK; Lee BS; Kim DH; Lim JS
    Scand J Infect Dis; 2013 Jun; 45(6):460-8. PubMed ID: 23294036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.
    Squarcione S; Sgricia S; Biasio LR; Perinetti E
    Vaccine; 2003 Mar; 21(11-12):1268-74. PubMed ID: 12559808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis.
    Beyer WE; Nauta JJ; Palache AM; Giezeman KM; Osterhaus AD
    Vaccine; 2011 Aug; 29(34):5785-92. PubMed ID: 21624411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
    Beyer WE; Palache AM; de Jong JC; Osterhaus AD
    Vaccine; 2002 Jan; 20(9-10):1340-53. PubMed ID: 11818152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new influenza subunit vaccine: reactogenicity and antigenicity in comparison to split and whole virus vaccines (author's transl)].
    Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz A; SchmidtG
    Infection; 1976; 4(2):73-9. PubMed ID: 947849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines.
    Andrews NJ; Walker WT; Finn A; Heath PT; Collinson AC; Pollard AJ; Snape MD; Faust SN; Waight PA; Hoschler K; Sheasby L; Waddington C; Kerridge S; Chalk J; Reiner A; John T; Fletcher M; Allen R; Fineman N; Wilkins S; Casey M; Michaelis L; Oeser C; Okike I; Ladhani S; Miller E
    Vaccine; 2011 Oct; 29(45):7913-9. PubMed ID: 21875635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children.
    Gross PA; Ennis FA; Gaerlan PF; Denson LJ; Denning CR; Schiffman D
    J Infect Dis; 1977 Nov; 136(5):623-32. PubMed ID: 335000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers.
    Jennings R; Clark A; Oxford JS; Hockley DJ; Potter CW
    J Infect Dis; 1978 Nov; 138(5):577-86. PubMed ID: 712115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly.
    Ruf BR; Colberg K; Frick M; Preusche A
    Infection; 2004 Aug; 32(4):191-8. PubMed ID: 15293073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age.
    Waddington C; Andrews N; Hoschler K; Walker W; Oeser C; Reiner A; John T; Wilkins S; Casey M; Eccleston P; Allen R; Okike I; Ladhani S; Sheasby E; Waight P; Collinson A; Heath P; Finn A; Faust S; Snape M; Miller E; Pollard A
    Health Technol Assess; 2010 Oct; 14(46):1-130. PubMed ID: 20923610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies.
    Beyer WE; Palache AM; Kerstens R; Masurel N
    Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):65-70. PubMed ID: 8641306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with inactivated, virosomal influenza vaccine.
    de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM
    Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of influenza vaccine in elderly people: a systematic review and meta-analysis of randomized controlled trials, and its association with real-world effectiveness.
    Meng Z; Zhang J; Shi J; Zhao W; Huang X; Cheng L; Yang X
    Hum Vaccin Immunother; 2020 Nov; 16(11):2680-2689. PubMed ID: 32347787
    [No Abstract]   [Full Text] [Related]  

  • 19. Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.
    Glathe H; Lange W
    Drugs Aging; 1995 May; 6(5):368-87. PubMed ID: 7647426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The meta analysis on the safety and immunogenicity of domestic and imported split influenza virus vaccines].
    Zhao YW; Feng ZJ
    Zhongguo Yi Miao He Mian Yi; 2009 Feb; 15(1):19-26. PubMed ID: 20077670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.